We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Examples for "proteasome endopeptidase complex inhibitors"
1
That system is a target for anticancer strategies by using proteasomeinhibitors.
2
Nevertheless, the mechanisms of apoptosis induced by proteasomeinhibitors remain unclear.
3
Both Kyprolis and Velcade are members of a class known as proteasomeinhibitors.
4
Overall, these findings suggest proteasomeinhibitors as potential latency reversing agents.
5
Overall, we determined the unique and novel mechanism of FOXM1 suppression by proteasomeinhibitors.
Usage of proteasome inhibitor in English
1
The proteasomeinhibitor bortezomib is an efficacious apoptotic agent in many tumor cells.
2
Bortezomib is the first proteasomeinhibitor drug tested in human patients.
3
However, a significant proportion of patients who receive a proteasomeinhibitor-containing regime show cardiotoxicity.
4
Therefore, the proteasomeinhibitor MG132 should be further evaluated for combination therapy with TRAIL.
5
The introduction of proteasomeinhibitor and immunomodulatory drugs has considerably changed the treatment paradigm of multiple myeloma.
6
These results demonstrate the involvement of PRDM1beta in T-cell lymphoma, with possible therapeutic interference by the proteasomeinhibitor.
7
In the present study, we studied the effect of the proteasomeinhibitor MLN-273 in two HBV mouse models.
8
Finally, treatment of tumor cells with Ad-mda7 plus the proteasomeinhibitor bortezomib resulted in increased tumor cell killing.
9
Strikingly, inclusion of the proteasomeinhibitor bortezomib reduces thrombotic risk, yet the molecular basis for this observation remains unknown.
10
Rapid development of the small molecule proteasomeinhibitor bortezomib has yielded important clinical benefit for patients with multiple myeloma.
11
The proteasomeinhibitor bortezomib is approved by the US Food and Drug Administration for treatment of mantle cell lymphoma.
12
Application of the proteasomeinhibitor MG132 restored the ability of the Xcv ΔxopJ to attenuate the development of leaf necrosis.
13
We first generated a yeast strain with an epitope tagged proteasome subunit to which a proteasomeinhibitor could be applied.
14
The impact of in vitro exposure to the proteasomeinhibitor bortezomib was next evaluated in primary mantle cell lymphoma cells.
15
These studies explain a fundamental mechanism by which cells adapt to proteotoxic stress and suggest strategies to mitigate proteasomeinhibitor resistance.
16
We found that the reduction in tyrosinase levels that was induced by terrein was clearly recovered by MG-132, a proteasomeinhibitor.